1. Recognyz System Technology: An Introduction
by Sharon Moalem
In an effort to improve treatment and research in the field of rare diseases, Recognyz System
Technology was founded in 2010 to develop new technologies for understanding orphan, or rare,
diseases. Estimated to affect more than 25 million Americans, or one in 10,000 individuals, rare
diseases are often neglected and underrepresented compared to widespread health conditions like
cancer, heart disease, or diabetes. Recognyz seeks to create technologies that “will allow
healthcare practitioners to diagnose individuals with rare genetic conditions who otherwise
would not have been identified.” With the support of doctors, donors, and research participants,
Recognyz aspires to “unlock the science” behind neglected disorders to improve the lives of
individuals and the overall efficacy of medical technology.
Recognyz is affiliated with the National Organization for Rare Disorders, Orphanet,
CheckOrphan, and the National Human Genome Research Institute. For more information, visit
Recognyz.com.
About the Author:
Sharon Moalem is the founder and CEO of Recognyz System Technology. He holds a Doctor of
Philosophy in Human Physiology and has appeared on The Daily Show, The Today Show, and
Good Morning America as a guest expert.